Chronische myelomonozytäre Leukämie · Canine CMML · Myelomonozytäre Leukämie Hund · Myeloproliferative Erkrankung Hund
Chronic myelomonocytic leukemia (CMML) is a severe, rare blood cancer originating in the bone marrow, where the body produces an uncontrolled excess of abnormal white blood cells. This overproduction crowds out healthy blood cells, impairing normal blood functions like oxygen transport and immune defense. A definitive diagnosis requires a complete blood count and a bone marrow biopsy, which is the gold standard method for identifying this condition.
The disease typically develops gradually in older dogs. Owners may notice progressive symptoms such as lethargy, unexplained weight loss, pale gums, or an enlarged abdomen caused by swelling of the liver or spleen.
While there is no cure, lifelong palliative chemotherapy and supportive care can help maintain the dog's quality of life. Managing this severe condition is costly, with treatment and ongoing monitoring typically ranging from 3,000 to 10,000 EUR.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the Spine.